Cargando…
Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study
BACKGROUND: Some patients with warm autoimmune haemolytic anaemia (wAIHA) or Evans syndrome (ES) have no response to glucocorticoid or relapse. Recent studies found that sirolimus was effective in autoimmune cytopenia with a low relapse rate. METHODS: Data from patients with refractory/relapsed wAIH...
Autores principales: | Zhang, Zhuxin, Hu, Qinglin, Yang, Chen, Chen, Miao, Han, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653746/ https://www.ncbi.nlm.nih.gov/pubmed/37967535 http://dx.doi.org/10.1080/07853890.2023.2282180 |
Ejemplares similares
-
Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial
por: Wan, Ziqi, et al.
Publicado: (2023) -
Comparison of eltrombopag and avatrombopag in the treatment of refractory/relapsed aplastic anemia: a single-center retrospective study in China
por: Zhang, Zhuxin, et al.
Publicado: (2023) -
Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
por: Zhang, Lina, et al.
Publicado: (2021) -
Autoimmune Haemolytic Anaemia and Multiple Autoimmune Syndrome
por: Sereshki, Mohammad Mahdi Adib, et al.
Publicado: (2019) -
Antibodies to actin in autoimmune haemolytic anaemia
por: Felder, Kathrin M, et al.
Publicado: (2010)